 Effect anticoagulant biocompatibility membrane plasmapheresis effect heparin citrate anticoagulation blood cellular complement pathway coagulation pathway membrane plasma exchange procedure membrane plasma separators cellulose di-acetate CA polyvinyl chloride PVC heparin anticoagulation year old male myasthenia gravis Maximum white blood cell decrease min CA heparin decrease schemes Platelet changes comparable heparin citrate PVC groups changes CA groups CA groups type anticoagulant complement activation classical pathway module addition activation alternative pathway CA heparin PVC groups complement activation heparin anticoagulation PT PTT slight increases citrate heparin Citrate changes cellular humoral factors CA heparin activating combination membrane material anticoagulant PVC citrate activating combination